kurt machemer

Kurt is a Principal at Faber Daeufer & Itrato PC. Kurt focuses his practice on meeting the business and legal needs of emerging growth companies in the life sciences and technology sectors, as well as venture capitalists and other investors in early stage companies.

He represents organizations at various stages of development, including companies with marketed pharmaceutical products, medical devices/diagnostics, and various innovative drug development programs.

Kurt joined the Pathway to Possible Board of Directors in May of 2024.